Literature DB >> 15954918

Interleukin-1 gene cluster polymorphisms predict risk of ESRD.

James B Wetmore1, Adriana M Hung, David H Lovett, Saunak Sen, Omer Quershy, Kirsten L Johansen.   

Abstract

BACKGROUND: Patients with chronic kidney disease manifest an inflammatory state relative to healthy individuals. Inflammation is regulated in part by genes of the interleukin-1 (IL-1) gene cluster. We hypothesized that polymorphisms in this gene cluster may be associated with risk of end-stage renal disease (ESRD).
METHODS: Polymorphisms in the IL-1 gene cluster were examined in a cohort of 239 racially diverse hemodialysis (HD) patients and 252 controls. These individuals were genotyped for 3 single nucleotide polymorphisms (SNPs) in the IL-1alpha and beta genes, and a variable-number-of-tandem-repeats polymorphism in the IL-1 receptor antagonist gene (IL-1RN). Polymorphisms were analyzed by logistic regression for their independent associations with ESRD, and the effect of allele dose of IL-1RN on risk for ESRD was examined. The interaction between race and genotype was also investigated.
RESULTS: A logistic regression model demonstrated that homozygosity for allele 2 of the IL-1RN variable-number-of-tandem-repeats (VNTR) polymorphism was associated with ESRD independent of race (P < 0.0005). The IL-1alpha-889 promoter SNP was associated with ESRD independent of race and of the IL-1RN polymorphism (P= 0.04). The IL-1beta-511 promoter SNP is associated with ESRD, but this is accounted for by race (P= 0.04).
CONCLUSION: Two polymorphisms within the IL-1 gene cluster are associated with ESRD independent of race. This finding is one of the strongest associations between genotype and ESRD reported, and suggests that polymorphisms in the IL-1 gene cluster affect the risk of development of ESRD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15954918     DOI: 10.1111/j.1523-1755.2005.00403.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury.

Authors:  Irina A Leaf; Shunsaku Nakagawa; Bryce G Johnson; Jin Joo Cha; Kristen Mittelsteadt; Kevin M Guckian; Ivan G Gomez; William A Altemeier; Jeremy S Duffield
Journal:  J Clin Invest       Date:  2016-11-21       Impact factor: 14.808

Review 2.  Targeting innate immunity-driven inflammation in CKD and cardiovascular disease.

Authors:  Thimoteus Speer; Stefanie Dimmeler; Stefan J Schunk; Danilo Fliser; Paul M Ridker
Journal:  Nat Rev Nephrol       Date:  2022-09-05       Impact factor: 42.439

3.  Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy.

Authors:  Xueling Liao; Yanan Xiao; Ulf Elbelt; Karsten H Weylandt; Kanghui Li; Jie Deng; Ning Zeng; Chao Xue
Journal:  Biomed Res Int       Date:  2022-05-25       Impact factor: 3.246

4.  Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients.

Authors:  James B Wetmore; David H Lovett; Adriana M Hung; Galen Cook-Wiens; Jonathan D Mahnken; Saunak Sen; Kirsten L Johansen
Journal:  Nephrology (Carlton)       Date:  2008-09-25       Impact factor: 2.506

5.  Association of genetic variants with chronic kidney disease in Japanese individuals.

Authors:  Tetsuro Yoshida; Kimihiko Kato; Tetsuo Fujimaki; Kiyoshi Yokoi; Mitsutoshi Oguri; Sachiro Watanabe; Norifumi Metoki; Hidemi Yoshida; Kei Satoh; Yukitoshi Aoyagi; Yutaka Nishigaki; Masashi Tanaka; Yoshinori Nozawa; Genjiro Kimura; Yoshiji Yamada
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

6.  Interleukin-1beta, but not interleukin-6, enhances renal and systemic endothelin production in vivo.

Authors:  Erika I Boesen; Jennifer M Sasser; Mohamed A Saleh; William A Potter; Mandy Woods; Timothy D Warner; Jennifer S Pollock; David M Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-04

7.  Differential regulation of endothelial cell activation by complement and interleukin 1alpha.

Authors:  Gregory J Brunn; Soheyla Saadi; Jeffrey L Platt
Journal:  Circ Res       Date:  2006-03-02       Impact factor: 17.367

Review 8.  Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.

Authors:  Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2016-08-11       Impact factor: 10.121

9.  Association of genetic variants with chronic kidney disease in Japanese individuals with or without hypertension or diabetes mellitus.

Authors:  Tetsuro Yoshida; Kimihiko Kato; Kiyoshi Yokoi; Mitsutoshi Oguri; Sachiro Watanabe; Norifumi Metoki; Hidemi Yoshida; Kei Satoh; Yukitoshi Aoyagi; Yoshinori Nozawa; Yoshiji Yamada
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

10.  Novel gene variants predict serum levels of the cytokines IL-18 and IL-1ra in older adults.

Authors:  A M Matteini; J Li; E M Lange; T Tanaka; L A Lange; R P Tracy; Y Wang; M L Biggs; D E Arking; M D Fallin; A Chakravarti; B M Psaty; S Bandinelli; L Ferrucci; A P Reiner; J D Walston
Journal:  Cytokine       Date:  2013-10-29       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.